![]() |
|
| C8 Study results - Publications | |
|
|
Serum Perfluorooctanoate (PFOA) and Perfluorooctane Sulfonate (PFOS) Concentrations and Liver Function Biomarkers in a Population with Elevated PFOA Exposure
Gallo V, Leonardi G, Genser B, Lopez-Espinosa M-J, Frisbee SJ, Karlsson L, Ducatman AM, Fletcher T. Relationships of Perfluorooctanoate and Perfluorooctane Sulfonate Serum Concentrations Between Child-Mother Pairs in a Population with Perfluorooctanoate Exposure from Drinking Water
Mondal D, Lopez-Espinosa M-J, Armstrong B, Stein CR, Fletcher T. Serum Perfluorinated Compound Concentration and Attention Deficit/Hyperactivity Disorder in Children 5–18 Years of Age
Stein CR, Savitz DA. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project
Shin H-M, Vieira VM, Ryan PB, Steenland K, Bartell SM. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with age of puberty among children living near a chemical plant.
Lopez-Espinosa M-J, Fletcher T, Armstrong B, Genser B, Dhatariya K, Mondal D, Ducatman A, Leonardi G. Comparison between free serum thyroxine levels, measured by analog and dialysis methods, in the presence of perfluorooctane sulfonate and perfluorooctanoate.
Lopez-Espinosa M-J, Fitz-Simon N, Bloom MS, Calafat AM, Fletcher T. Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington Works Facility in West Virginia.
Shin H-M, Vieira VM, Ryan PB, Detwiler R, Sanders B, Steenland K, Bartell SM. Private drinking water wells as a source of exposure to PFOA in communities surrounding a fluoropolymer production facility.
Hoffman K, Webster TF, Bartell SM, Weisskopf MG, Fletcher T, Vieira VM. Accumulation and clearance of PFOA in current and former residents of an exposed community.
Seals R, Bartell SM, Steenland K. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: Results from the C8 Health Project.
Frisbee SJ, Shankar A, Knox SS, Steenland K, Savitz DA, Fletcher T, Ducatman AM. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA).
Steenland K, Fletcher T, Savitz DA. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA.
Steenland K, Tinker S, Shankar A, Ducatman A. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia.
Bartell SM, Calafat AM, Lyu C, Kato K, Ryan PB, Steenland K. The C8 Health Project: Design, methods, and participants.
Frisbee SJ, Brooks AP Jr, Maher A, Flensborg P, Arnold S, Fletcher T, Steenland K, Shankar A, Knox SS, Pollard C, Halverson JA, Vieira VM, Jin C, Leyden KM, Ducatman AM. A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA).
MacNeil J, Steenland NK, Shankar A, Ducatman A. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant.
Steenland K, Tinker S, Frisbee S, Ducatman A, Vaccarino V. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome.
Stein CR, Savitz DA, Dougan M. Predictors of PFOA levels in a community surrounding a chemical plant.
Steenland K, Jin C, MacNeil J, Lally C, Ducatman A, Vieira V, Fletcher T. Note on accessing the full articles: for some of the above articles only the abstract is available online. This means that a photocopy or an online pdf document version of the full text of the article can only be obtained from the authors, from someone who has (or a library which has) subscribed to the journal, or by paying online to the journal. |